Namita Thapar-backed Emcure Pharma IPO opens: GMP, price, apply or not? | News on Markets
The Namita Thapar-backed Emcure Pharma IPO has opened for subscription with a price band of Rs 594-600 per share. The ...
The Namita Thapar-backed Emcure Pharma IPO has opened for subscription with a price band of Rs 594-600 per share. The ...
Indian government bonds have been included in JP Morgan's bond index, a move that signifies the growing confidence in India's ...
A Labour supermajority would likely lead to increased government intervention in the economy, potentially impacting capital markets. Investors may be ...
Specialty chemicals companies are seeing a surge in their stock prices, with some shares rallying up to 9%. Leading players ...
In the world of financial markets, calm seas never made a skilled sailor. It is during times of turbulence and ...
Buoyed by strong capital markets in 2023, the average annual total shareholder return (TRS) surged across the companies, according to ...
Alexis George: AMP chief AMP has reported modest growth in NZ funds under management during the March quarter with investment ...
The markets are mercurial but their tone has thoroughly changed — from the sky-is-the-limit bullishness that dominated only a month ...
The financial market is dynamic, constantly shifting, and evolving in response to various economic factors. One of the most significant ...
South Africa's popular markets have recently achieved global recognition, with two markets in Gauteng making it to the top 20 ...
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.